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Abstract
Background: Patients with heart failure often suffer from multiple co-morbid conditions. However, until now only cardiovascular co-
morbidity has been well described.
Aims: To understand heart failure in the context of multi-morbidity, by describing the age and sex specific patterns of non-cardiovascular co-
morbidity in elderly patients with heart failure in general practice.
Methods: All patients aged 65 years and over, diagnosed with heart failure in four practices of the Nijmegen Academic Practice-based
Research Network (NPBRN) between January 1999 and December 2003 were selected, and the prevalence of 27 cardio- and non-
cardiovascular co-morbidities determined.
Results: Of the 269 patients identified (mean age 79 years; 57% women), 80.2% had four or more co-morbidities. With increasing age, a
significant increase in the prevalence of non-cardiovascular conditions like visual and hearing impairments, osteoarthritis, dementia and urine
incontinence; and a decrease in cardiovascular conditions like myocardial infarction and in women, hypertension, was observed. In patients
aged 85 years and over, non-cardiovascular disorders predominated over cardiovascular disorders.
Conclusions: In elderly patients with heart failure, the prevalence of non-cardiovascular co-morbidity is very high and exceeds the prevalence
of cardiovascular conditions. Diseases such as dementia and osteoarthritis must be taken into account in the management of elderly patients
with heart failure.
© 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Heart failure has become a very prevalent health con-
dition in elderly patients. Recent studies of the population
prevalence of heart failure in the UK and The Netherlands
have reported a prevalence of between 7.1 and 8.3 per 1000
persons, increasing with age, from 90 per 1000 in patients
aged 65–74 years, up to 174 per 1000 patients aged 85 years
and over [1–3]. Consequently, diagnosis and management of
heart failure consumes approximately 2% of the national
health care budgets of most industrialized countries [4], the
majority being spent on elderly patients aged 65 years and
older [5].
One of the major characteristics of elderly patients is the
presence of multi-morbidity [6,7]. Since the average age at
heart failure diagnosis is 80 years, most patients with heart
failure will therefore suffer from multiple health conditions
[8]. A substantial part of these co-morbid health conditions
will be age-related, non-cardiovascular disorders.
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Although the importance of co-morbidity is recognised,
there is a paucity of empirical data on the diagnosis and
management of heart failure in the presence of co-morbidity.
Available data are directed predominantly at underlying
causative cardiovascular conditions [9]. However, with the
ageing of the heart failure population, the presence of age-
related, non-cardiovascular co-morbidity has become in-
creasingly relevant. Co-morbidity may interfere with the
diagnosis and treatment of heart failure or resulting health
gains and quality of life. In the same way, heart failure may
influence the diagnosis and treatment of concomitant
disorders [10].
The frequency of some non-cardiovascular co-morbid-
ities in hospital and nursing home populations has been
reported [11,12] and two studies have demonstrated the
negative influence of non-cardiovascular co-morbidities on
patient outcomes [5,13]. Recently, Dahlström described four,
prevalent non-cardiac co-morbidities (hypertension, diabetes
mellitus, COPD and anaemia) in terms of epidemiology,
mechanisms linked to heart failure, treatment and prognosis
[14]. The author concluded that early detection of concom-
itant diseases in patients with heart failure is important and
should be considered when initiating therapy.
To support this early detection, better insight into the
occurrence of co-morbidity in elderly patients with heart
failure is essential. To our knowledge no previous study has
comprehensively reported on the prevalence of (non-cardio-
vascular) co-morbidity in a general population of elderly
patients with heart failure.
The aim of this study was therefore, to describe the
prevalence of cardiovascular and non-cardiovascular health
conditions in patients, aged 65 years and older with heart
failure in general practice and to relate this to their
demographic characteristics.
2. Methods
2.1. Database and population
We extracted data from the Continuous Morbidity
Registration (CMR). This database contains data from 4
general practices which are part of the Nijmegen academic
Practice-Based Research Network (NPBRN), in the Nether-
lands. The practices are fully computerized and have ap-
proximately 14,000 patients listed with a sex and age
distribution representative of the Dutch population. The
database is particularly suitable for studying longitudinal
data and tracking morbidity. Since 1971 ongoing, all epi-
sodes of morbidity presented to the general practitioner,
diagnoses made by specialists after referral, and cause of
death are registered with the use of the diagnostic criteria
of the International Classification of Health Problems in
Primary Care (ICHPPC)-2-defined [15–17]. These diagnos-
tic criteria are also used in the Guidelines of the Dutch
College of General Practitioners, including the Guideline for
heart failure [18]. The quality of the data is maintained by
regular instruction and training sessions on diagnosis and
coding and by quality control measures [19]. If a diagnosis
turns out to be incorrect, correction to the appropriate diag-
nostic code will be made at the start of the episode and the
date of first presentation. For this study we selected all
patients aged 65 years and over, with a record of “heart
failure” between 01-01-1999 and 31-12-2003.
2.2. Heart failure and co-morbidity
The diagnosis “heart failure” was based on the criteria of
the first edition (1995) of the guideline “Heart failure” of the
Dutch College of General Practitioners [18]. In this edition,
heart failure was not defined according to the current cri-
teria for heart failure as set by the European Society of
Cardiology [20]. The use of echocardiography was not
actively advocated and the diagnosis was made based on
history, physical examination and additional investigations
(ECG, chest X-ray). The diagnosis was made in adults with
exertional breathlessness and/or reduced exercise tolerance
due to breathlessness or fatigue and one or more of the
following: paroxysmal nocturnal breathlessness or orthop-
noea; pulmonary basal crepitations; raised jugular venous
pressure; third heart sound; chest X-ray with heart–thorax
ratio N0.50 or interstitial pulmonary oedema or venous
redistribution; history of ejection fraction b0.4. In addition,
signs and symptoms to support the diagnosis were described:
history of relevant cardiovascular disease; tachycardia or
irregular pulse; heart murmur; peripheral oedema and
palpable liver.
In order to substantiate the validity of the diagnosis in our
studied population, we retrospectively analyzed data of a
random selection of 100 patients. We reviewed the medical
files on the diagnostic process applied by the general prac-
titioner, including the results of any referrals to a cardi-
ologist. The diagnosis of heart failure was deemed to be valid
when either the Walma score was positive or if the diagnosis
was confirmed by a cardiologist [21].
Co-morbidity was defined as the coexistence of one or
more health conditions in a patient with an index disease
(in our study this was heart failure) [22]. Co-morbidity was
assessed either at the date of diagnosis or at the date of cohort
entry (01-01-1999) in case of known patients with heart
failure. We selected co-morbidities based on an analysis of
all chronic conditions present in the studied population. The
20 most prevalent conditions were chosen for further study
(Table 1). We also defined 10 non-cardiovascular health
conditions of a priori interest (rheumatoid arthritis, osteo-
arthritis, deafness, visual impairments, syncope, dizziness,
dementia, depression, anaemia, and thyroid dysfunction).
These conditions were included in our study, even if they
were not in the top 20. Of the top 20, we excluded
“conditions of eye; others” because of its obscure definition.
In addition, we combined all types of osteoarthritis and
combined cataract, glaucoma and blindness as “visual
impairments”. All studied co-morbidities were defined
710 M.C. van der Wel et al. / European Journal of Heart Failure 9 (2007) 709–715
 at K
atholieke U
niversiteit on July 11, 2012
http://eurjhf.oxfordjournals.org/
D
ow
nloaded from
 
according to the diagnostic criteria of the International Clas-
sification of Health Problems in Primary Care (ICHPPC)-2-
defined [15–17].
2.3. Statistical analysis
Exact binomial distribution and the Poisson distribution
were used to calculate 95% confidence intervals for the
prevalence and incidence (in person years) respectively. We
used Maentel Haenszel Chi square tests to determine age
trends in the whole study group and according to sex for
changes in the prevalence of all studied co-morbidities.
Differences in prevalent co-morbidity between the sexes per
age group were determined using Chi square tests. Due to
the explorative nature of our study corrections for multiple
testing were not indicated. All statistical analyses were
performed with SAS software version 9.1.
3. Results
In the CMR, 269 patients aged 65 years and over were
registered as having heart failure, the characteristics of these
patients are given in Table 1. In 150 patients heart failure
had been diagnosed before 1999 and in the remaining 119
patients heart failure was diagnosed during the study period.
In a random sample of 100 patients, 92% of all heart failure
diagnoses were confirmed by either a positive Walma score
and/or assessment by a cardiologist.
The selection of co-morbidities as described in the
Methods section resulted in 27 health conditions to be
studied. Three of the 10 conditions of a priori interest
proved to be part of the top 20 most prevalent health
conditions. In total, the studied health conditions made up
over 70% of all recorded chronic conditions in the studied
population.
The incidence and prevalence of heart failure increased
substantially with age. The incidence increased from 0.7
(0.3–1.3)% in patients aged 65–74 years and 1.9 (1.2–3.0)%
in patients aged 75–84 years to 4.7 (3.5–6.1) % in those aged
85 years and over. The prevalence increased from 3.3 (2.8–
3.8) % and 13.1 (11.9–14.4) % to 26.2 (23.1–29.5) %
respectively (95% CI in parentheses).
Table 2 denotes the age and sex specific distribution of the
number of co-morbidities. At least one co-morbid condition
was present in each patient. In patients aged 65 years and
over four or more co-morbidities were present in 80.2% and
six or more co-morbidities in 45.3%. The distribution of
the number of co-morbidities differed between age groups;
with advancing age the median number of co-morbidities
increased.
Table 2
Sex and age specific number of co-morbidities (% of patients) in patients aged 65 years and over with heart failure
Age group
(yrs)
Men Women Total
64–74 75–84 85+ 65–74 75–84 85+ 65–74 75–84 85+
n=46 n=56 n=13 n=29 n=68 n=57 n=75 n=124 n=70
Co-morbidities
0 0 0 0 0 0 0 0 0 0
1–3 32.6 19.6 0 27.6 16.2 14.0 30.1 17.7 11.4
4–5 30.4 39.3 61.5 37.9 27.9 35.1 33.3 33.1 40.0
6–7 28.3 28.6 23.1 24.1 26.5 35.1 26.7 27.4 32.9
N7 8.7 12.5 15.4 10.3 29.4 15.8 9.3 21.7 15.7
Percentages may not add up exactly to 100 because of rounding.
Table 1
Patient characteristics and the 20 most prevalent chronic health conditions in
the study population
Variables
Number of patients 269
Age distribution (n)
65–74 years 75
75–84 years 124
85+ years 70
Mean age in years (SD) 79.2 (7.8)
Sex (%)
Women 57.2
Men 42.8
Top 20 most prevalent chronic co-morbidities (%)
Hypertension 37.5
Cataract 37.2
Varicose veins/CVI 37.2
Overweight (25bQI≤30) 33.8
Atrial fibrillation 32.3
Deafness 30.5
Diabetes mellitus 29
Osteoarthritis of knee 28.6
Angina Pectoris 27.9
TIA/CVA 25.7
Myocardial infarction 24.9
COPD 24.5
Obesity (QIN30) 20.8
Valve disorders 18.2
Urine incontinence 17.5
Malignancies 16
Nervous functional 15.6
Osteoarthritis of hip 15.6
Conditions of eye; others 15.2
Lipid metabolism disorders 12.3
SD = Standard deviation; CVI = chronic venous insufficiency; TIA =
Transient Ischaemic Attack; CVA = Cerebral Vascular Accident; COPD =
Chronic Obstructive Pulmonary Disease.
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The age and sex specific prevalence of co-morbidities
are depicted in Table 3. To improve readability, results
of 6 co-morbidities all of which the age or sex specific
highest prevalence did not exceed 10% were left out of
Table 3. In the age group 65–74 years, there was a
tendency for myocardial infarction to be more prevalent in
men (41.3% vs. 20.7%) (p=0.065). In contrast, in the age
group 75 to 84 years significantly more women suffered
from hypertension (52.9% vs. 33.9%; p=0.034), arthritis
(39.7% vs. 14.3%; p=0.002); obesity (20.6% vs. 5.4%;
p=0.014) and thyroid disorders (16.2% vs. 1.8%; p=
0.007) than men. No significant differences between men
and women were observed in the age groups of 85 years
and over.
In addition, Table 3 shows a changing pattern in the
prevalence of co-morbiditieswith advancing age.With ageing,
non-cardiovascular disorders became increasingly more
important in terms of prevalence. There was a significant
increase with age in the prevalence of dementia (pb0.0001);
urine incontinence ( pb0.0001), hearing impairment
(pb0.0001), visual impairment (p=0.0001), varicose veins
or chronic venous insufficiency (p=0.018) and osteoarthritis
(p=0.0002). In addition, the prevalence of COPD (p=0.045),
lipid metabolism disorders (p=0.019), obesity (0.016) and
myocardial infarction (p=0.007) decreased significantly. In
women, the prevalence of hypertension decreased significant-
ly (p=0.009) with advancing age, while in men there was
virtually no change. Finally, inmen the prevalence of disorders
of lipid metabolism decreased significantly ( p=0.023)
compared to women.
4. Discussion
The elderly patients with heart failure in this study
suffered from an array of concomitant disorders in addition
to heart failure, with four or more co-morbidities present in
over 80% of patients. The prevalence of these co-morbidities
differed depending on age and sex. As expected, the
prevalence of age-related non-cardiovascular conditions
like hearing and visual impairments, urine incontinence,
osteoarthritis and dementia rose significantly with increasing
age. However, to our surprise the prevalence of myocardial
infarction and hypertension (in women) decreased signifi-
cantly with advancing age.
4.1. Interpretation of results
Our findings on the number of co-morbidities present in
patients with heart failure are in agreement with previous
reports [5,11,12]. The number and type of co-morbidities
present have important implications. It is known that the
presence of multi-morbidity has a negative effect on
activities in daily life (ADL), quality of life (QoL) and
prognosis [7,23,24].
Table 3
Age and sex specific prevalence of co-morbidities in patients aged 65 years and over with heart failure
Co-morbidity Men by age group Women by age group Men and women by age group
65–74 75–84 85+ 65–74 75–84 85+ 65–74 75–84 85+
n=46 n=56 n=13 n=29 n=68 n=57 n=75 n=124 n=70
Anaemia 8.7 17.9 15.4 6.9 16.2 15.8 8 16.9 15.7
Angina pectoris 37 37.5 23.1 34.5 30.9 21.1 36 33.9 21.4
Atrium fibrillation or flutter 39.1 39.3 38.5 34.5 39.7 36.8 40 39.5 34.7
COPD 39.1 35.7 38.5 20.7 22.1 12.3 32 28.2 17.1 a
CVA or TIA 23.9 28.6 46.2 27.6 33.8 28.1 25.3 31.5 31.4
Dementia 0 12.5 15.4 a 3.4 7.4 22.8 a 1.3 9.7 21.4 a
Diabetes Mellitus 37 30.4 38.5 24.1 38.2 17.5 32 34.7 21.4
Hearing impairment 19.6 33.9 46.2 a 17.2 25 56.1 a 18.7 29 54.3 a
Hypertension 34.8 33.9 b 30.8 48.3 52.9 b 24.6 a 40 44.4 25.7
Lipid metabolism disorders 23.9 12.5 0 a 6.9 16.2 5.3 17.3 14.5 4.3 a
Malignancies 28.3 32.1 30.8 20.7 23.5 14 25.3 27.4 17.1
Myocardial infarction 41.3 41.1 15.4 20.7 29.4 14 33.3 34.7 14.3 a
Nervous Functional 21.7 19.6 30.7 34.5 30.9 18.8 26.7 25.8 28.6
Obesity (QIN30) 39.1 5.4 b 23.1 31 20.6 b 19.3 36 13.7 20 a
Osteoarthritis 40 41.1 b 61.5 37.9 57.4 b 70.2 a 37.3 50 68.6 a
Overweight 23.9 37.5 46.2 31 41.2 31.6 26.7 39.5 34.3
Thyroid dysfunction 0 1.8 b 0 13.8 16.2 b 14 5.3 9.7 11.4
Urine incontinence 2.2 14.3 23.1 a 24.1 20.6 47.4 a 10.7 17.7 42.9 a
Visual impairments 23.9 41.1 53.8 a 24.1 51.5 56.1 a 24 46.8 55.7 a
Valvular disorders 17.4 17.9 23.1 24.1 26.5 12.3 20 22.6 14.29
Varicose veins or CVI 17.4 b 25 b 15.4 b 44.8 b 61.8 b 54.4 b 28 45.2 47.1 a
QI = Quetelet index; CVI = Chronic Venous Insufficiency; TIA = Transient Ischaemic Attack; CVA = Cerebral Vascular Accident; COPD = Chronic Obstructive
Pulmonary Disease. Hypertension (systolic or diastolic); visual impairment (cataract or blindness or glaucoma); overweight (25bQIb30); diabetes (insulin or
non-insulin dependent); malignancies (any category). All values are percentages.
a Significant age trend ( pb0.05).
b Significant difference between men and women in similar age group.
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While cardiovascular conditions like hypertension, myo-
cardial infarction and angina pectoris are the most prevalent
co-morbidities in patients aged 65–74 years, age-related health
conditions not related to heart failure like dementia, hearing
and visual impairments, osteoarthritis and urine incontinence
predominate in the very elderly patient. Our results clearly
demonstrate the need for an expansion of the focus on co-
morbidity in patients with heart failure from merely the
cardiovascular diseases towards prevalent non-cardiovascular
health conditions, as described in this study.
We reported the incidence and prevalence of the best
available general practice diagnosis of heart failure, which
differs from previous reports and suggests that one in four
very elderly patients has heart failure [1–3]. We realize that
heart failure diagnosis in general practice often does not meet
cardiologic standards. Most importantly, the use of echocar-
diography by general practitioners is limited by doctor,
patient and organizational factors [25,26].
Although it appears to be a poor excuse to exclude patients
with high age and frailty from having a correct diagnosis, the
fact of the matter is that the combination of benign pater-
nalistic views from doctors and patients wishing to avoid
(hospital-based) additional investigations, prevents strict
adherence to the scientifically just, but not patient orientated
guidelines. Our validation technique with the unique reg-
istration methodology to eliminate incorrect registration of
diagnoses (see Method section) and the use of combined
cardiologist confirmed diagnosis and Walma score may not
entirely meet ESC criteria, but seems to be a reasonable basis
for interpretation of the current data in the context of general
practice. The Walma score has similar diagnostic strength as
both the Framingham and Boston scores [27]. With the
current study design it was not possible to – in retrospect –
assess cardiac function by echocardiography.
From a pathophysiological perspective, the decrease in
the prevalence of hypertension in women is unexpected.
These findings are not in agreement with the results of
previous studies showing that hypertension is the major
contributor in the development of heart failure due to
diastolic dysfunction — a condition most prevalent in
elderly patients and women [28,29]. However, results from a
national survey in Scotland demonstrated that the number of
consultations for hypertension drop steeply in patients aged
85 years and over [2]. It is possible that since doctors know
the effect of preventive strategies in these older patients is
limited, they will tend to under register and diagnose
hypertension. Another explanation may be that patients with
hypertension are at elevated risk for myocardial infarction
and CVA and may not have survived to the age of 85+ years.
The presence of non-cardiovascular co-morbidity may
hamper performance of meaningful interventions like self
management and the use of effective medication in the
management of heart failure. For instance, heart failure in
patients with osteoarthritis may be exacerbated more frequent-
ly than in others, due to the use of over-the-counter NSAID's.
A recent study in the Netherlands on the use of over-the-
counter NSAID's showed a 14% usage of NSAID's in patients
with contraindications for NSAID use [30]. In addition, we
suspect a major influence of the presence of (mild) cognitive
impairment or dementia on both diagnosis andmanagement of
heart failure. Cognitively impaired patients are known to be
less compliant with treatment [31]. They forget to take their
medication and are difficult to train for non-medical interven-
tions like daily weight control and exercise. Dementia, or its
precursor mild cognitive impairment [31], was present in just
under a quarter of our study population aged 85 years and over,
this is probably an underestimation given the reported under
diagnosis of dementia in general practice [32–34]. Several
studies have suggested that heart failure is a contributing factor
in the development of vascular cognitive impairment [35,36].
If so, a vicious circle can be imagined in which heart failure
deterioration leads to cognitive impairment, which may cause
increased non-adherence to heart failure treatment which
subsequently leads to further deterioration.
4.2. Strengths and limitations
The strengths of our study are the studied population of
elderly patients in general practice which represents the
majority of heart failure patients; the focus on heart failure in
the context of multi-morbidity and the unique, comprehen-
sive description of the age and sex specific prevalence of an
array of non-cardiovascular co-morbidities.
Some limitations are worth considering. First, over- and
under diagnosis of heart failure in general practice is known
and is in part a consequence of the presence of co-morbidity
[37–39]. With the restriction of not having used echocardi-
ography or an expert panel as the gold standard for diagnosis,
we proved the diagnosis of heart failure in the CMR to
be valid within the context of our study design and popu-
lation. Our results should primarily be interpreted in the
perspective of general practice, bearing in mind that the
presented prevalence figures may be an overestimation of
actual prevalence.
Secondly, only 70 patients in our study were aged
85 years or older. This limited number of very elderly
patients may be acceptable for a descriptive study, but larger
numbers will be required for future studies on the actual
effect of non-cardiovascular co-morbidity on the diagnosis
and management of heart failure. Finally, the number of co-
morbidities studied was not infinite. Whether our list of
studied co-morbidities was sufficient is open to debate.
However, due to our step-wise selection approach we could
not overlook any prevalent or relevant co-morbidity. To our
knowledge the age and sex specific prevalence of co-
morbidity in patients with heart failure in general practice
has not previously been studied to this extent.
4.3. Future considerations
Ideally, a management guideline for heart failure – or any
other chronic condition in elderly patients – should take
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factors like co-morbidity and polypharmacy into account. A
suggestion for guideline developers may be to clearly mark
which treatment step results in the biggest health gain and/or
QoL gain. In this way the doctor–patient decision to only
partly follow a disease specific guideline can be directed
towards the most optimal treatment choice.
Our results confirm that management of heart failure in
elderly patients demands a patient orientated approach with
awareness for and management of multi-morbidity [40,41].
Current heart failure disease management programs may
be improved by inclusion of expertise from generalists.
Geriatricians for instance could diagnose typical geriatric
conditions and advise on heart failure management in the
context of their findings [42]. However, current medical
expertise in the majority of heart failure management
programs is limited to cardiologist and/or specialized heart
failure nurses [43].
Future studies should evaluate the actual effect of the
presence of non-cardiovascular co-morbidities on heart
failure diagnosis and management, and identify effective
management strategies aimed at elderly patients with heart
failure and co-morbidity.
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